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OBSERVATION
Exonic Deletions of FXN and Early-Onset
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Background: Friedreich ataxia (FA) is the most fre-
quent type of autosomal recessive cerebellar ataxia, oc-
curring at a mean age of 16 years. Nearly 98% of pa-
tientswith FApresentwith homozygousGAA expansions
in the FXN gene. The remaining patients are compound
heterozygous for an expansion and a point mutation. Pa-
tients who are compound heterozygous for an exonic de-
letion and an expansion are exquisitely rare.
Objectives: To describe 6 patients affected with FA due
to an exonic deletion mutation (FAexdel) and to com-
pare these 6 patients with FAexdel with 46 patients con-
secutively diagnosed with typical FA due to homozy-
gous GAA expansion and whose small expansions were
within the same range as that of the expansions of the
patients with FAexdel.
Design: Description of a series.
Setting: Academic research.
Patients: Six patients with FAexdel and 46 patients with
typical FA.
Intervention: FXN gene analysis, including assess-
ments of GAA expansion and exon sequencing and de-
termination of exonic copy numbers using multiplex li-
gation-dependent probe amplification.
Results: We identified 6 patients with FA who pre-
sented with the combination of 1 GAA expansion and 1
FXN exonic deletion. The mean (SD) age at onset of the
disease was earlier for patients with FAexdel (7 [4] years
[range, 3-12 years]) than for patients with typical FA (15
[5] years [range, 6-30 years]) (P=.001), and the median
time to confinement to wheelchair was shorter for pa-
tients with FAexdel (20 years) than for patients with typi-
cal FA (28 years) (P=.002). There was no difference be-
tween themean (SD) size of the expansion for the patients
with FAexdel (780 [256] GAA triplet repeat sequences
[range, 340-1070GAA triplet repeat sequences]) and the
mean (SD) size of the short expansion for the patients
with typical FA (634 [163] GAA triplet repeat se-
quences [range, 367-1000 GAA triplet repeat se-
quences]) (P=.10). Themean disease duration before be-
coming wheelchair bound was shorter for patients with
FAexdel (9 years) than for patients with typical FA (13
years), and the incidence of cardiomyopathy was higher
for patients with FAexdel (84%) than for patients with
typical FA (68%). However, these differences were not
significant, probably owing to the small size of theFAexdel
group. The other extraneurological signs, such as sco-
liosis or diabetes mellitus, were particularly frequently
observed in the FAexdel group. One patient presented
at 9 years of age with severe angina and marked cardio-
myopathy that confined her to a wheelchair. Three pa-
tients had disabling autonomic disturbances. It appears
that exonic deletion significantly contributes to the clini-
cal picture of patients with FA.
Conclusions: Friedreich ataxia due to an exonic dele-
tion mutation corresponds to an early onset and severe
variant of FA. FXN should be investigated for exonic de-
letion in patients with early-onset FA in which only 1
GAA expansion without a point mutation is found. Pa-
tients with FAexdel have to be carefully observed using
cardiological, orthopaedic, endocrinological, gastroen-
terological, and ophthalmological data. Friedreich ataxia
due to an exonic deletion mutation should be suspected
in young patients presenting with severe scoliosis.
Arch Neurol. 2012;69(7):912-916. Published online
March 12, 2012. doi:10.1001/archneurol.2011.834
F RIEDREICHATAXIA (FA) IS THEmost frequent type of auto-somal recessive cerebellarataxia. First signs usually oc-cur at amean age of 16 years
old (mostly between 10 and 25 years).1
Friedreich ataxia is clinically character-
ized by the combination of both cerebel-
lar and proprioceptive ataxia, sensory neu-
ronopathy with loss of deep tendon
reflexes, extensor plantar responses, sco-
liosis, hypertrophic cardiomyopathy, and,
less frequently, diabetesmellitus.1-3 Nearly
98% of patients with FA present with ho-
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mozygous GAA expansions in the FXN gene encoding
the frataxin protein.4 About 2%of these patients have both
1 GAA expansion and 1 point mutation in FXN. Pa-
tients compound heterozygous for an exonic deletion and
an expansion are exquisitely rare.5 Although the clinical
phenotype of FA due to GAA expansion1 or point mu-
tations6 has been well described, the clinical spectrum
of patients with FA due to an exonic deletion mutation
(FAexdel) remains unknown.We report 6 patients with
FAexdel who presented with the combination of 1 GAA
expansion and 1 FXN exonic deletion responsible for
early-onset FAwith precocious neurological disability and
cardiomyopathy.
METHODS
Approximately 600 patients, recruited fromFrench centers dur-
ing the period from 1988 to 2010, received a diagnosis of FA,
whichwas determined by use of a genetic test. TheDNA samples
of 13 ataxic patients whose clinical phenotypes were compat-
ible with FA but who were heterozygous for a GAA expan-
sion4 and had no point mutation6 were assessed for large FXN
Table 1. Main Clinical, Molecular, Morphological, and Electrophysiological Features of 6 Patients With Friedreich Ataxia
Due to an Exonic Deletion Mutation
Feature Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Age at onset of ataxia, y 3 3 7 5 12 12
First sign Unsteadiness Scoliosis Unsteadiness Unsteadiness Unsteadiness Unsteadiness
Spinocerebellar degeneration
functional scorea
3/7 at 4 y, 6/7 at
12 and 14 y
6/7 at 9 and 30 y 6/7 at 24 y, 7/7 at
64 y, deceased at
69 y
2/7 at 9 y (ICARS
score, 19/100)
4/7 at 19 and 22
y, 5/7 at 27 y, 6/7
at 29 y
6/7 at 20 and 46
y
SARA score 28 at 14 y 36 at 30 y Unknown 12 at 9 y 27 at 29 y 34 at 46 y
Disease duration before becoming
wheelchair bound, y
9 6 17 NA 17 8
FXN molecular analysis 1070 GAA triplet
repeat
sequences
(exons 4 and 5
deleted)
800 GAA triplet
repeat
sequences
(exons 4 and 5
deleted)
970 GAA triplet
repeat
sequences
(exons 4 and 5
deleted)
670 GAA triplet
repeat
sequences
(exons 2 and 3
deleted)
340 GAA triplet
repeat
sequences
(exons 4 and 5
deleted)
830 GAA triplet
repeat
sequences
(exon 4
deleted)
Cerebellar ataxia? Yes Yes Yes Yes Yes Yes
Extensor plantar response? Yes Yes Yes No No Yes
Areflexia and/or vibration sense
loss?
Yes Yes Yes Yes Yes Yes
Motor deficit?b Severe hypotonia Yes (LL,
amyotrophy)
Yes (UL and LL,
amyotrophy)
No No Yes (LL,
amyotrophy)
Dysarthria? Yes Yes Yes No Yes Yes
Diabetes (age at diagnosis)? Yes (11 y) No Yes (48 y) No No Yes (31 y)
Cardiomyopathy (age at
diagnosis)?
Yes (4 y) Yes (at 9 y) and
severe angor
Yes (48 y) Yes (9 y) No Yes
Pes cavus (age at diagnosis)? Yes (4 y) Yes (and
equinovarus)
Yes No Yes NA
Scoliosis? Yes, arthrodesis
at 14 y
Yes, operated on
at 13 y
Yes NA Yes No
Loss of visual acuity? Myopia, optic
atrophy
No No No No NA
Hearing loss? No No Yes (bilateral 10-
to 20-dB
sensorineural
hearing loss)
No No Yes
Movement disorder? Yes (cerebellar
tremor)
Yes (cerebellar
tremor)
No Yes (head
tremor)
No No
Autonomic disturbance? Repeated ileus at
11 y
No Ileus No No Ileus at 49 y
Fundus examination findings (age
at diagnosis)
Optic neuropathy
(24 y)
Asymptomatic
optic
neuropathy
suspected
NA Normal Normal NA
EMG findings (age at diagnosis) Sensory
neuronopathy
(4 y)
Sensory
neuronopathy
(10 y)
NA Sensory
neuronopathy
Sensory
neuronopathy
Sensory
neuronopathy
MRI findings of the brain Normal Normal NA Normal Normal NA
MRI findings of the medulla
oblongata
NA Spinal cord
atrophy
NA NA Syringomyelic
cavity T7-T9
NA
Treatment with idebenone? Yes (10 mg/kg/d) NA NA Yes (mg/kg/d) No No
Abbreviations: EMG, electroneuromyography; ICARS, International Cooperative Ataxia Rating Scale; LL, lower limbs; MRI, magnetic resonance imaging;
NA, not available; SARA, Scale for the Assessment and Rating of Ataxia; UL, upper limbs.
aScore from 0 (no cerebellar sign) to 7 (bedridden), with 6/7 indicating that the patient is wheelchair bound.
bMotor deficit was defined by a score of 3/5 or less in muscle strength from the Oxford scale.
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deletion or duplication using a multiplex ligation-dependent
probe amplification kit (SALSA MLPA kit P316-A1 Recessive
Ataxias; MRC-Holland) according to the manufacturer’s rec-
ommendations. We retrospectively reviewed the clinical, mo-
lecular, electrophysiological, andmorphological data of the pa-
tients with FAexdel and of 46 patients consecutively diagnosed
with typical FA due to homozygous GAA expansion andwhose
small expansions were within the same range as that of the ex-
pansions of the patients with FAexdel.
Data, reported as mean (SD) values along with minimum
and maximum values (ie, range), were analyzed by use of the
Mann-Whitney test. When percentages were compared, the
Fisher exact test was used. For the median time to confine-
ment to a wheelchair and for the median disease duration be-
fore confinement to awheelchair, the Kaplan-Meiermethodwas
performed.
RESULTS
Seven patients had a normal FXN exonic copy number
dosage, excluding the diagnosis of FA. These patients,
whose molecular diagnosis remains unknown, pre-
sentedwith late-onset ataxia (ranging from 30 to 58 years
of age) and had large expansions (from 700 to 1100GAA
triplet repeat sequences). Some had atypical presenta-
tion because they had cerebellar atrophy and/or a lack
of sensory neuropathy. They were assumed to be het-
erozygous carriers of the expansion by chance, given the
high frequency of the GAA expansion in the European
population (1 in 90 individuals).7,8 The remaining 6 pa-
tients were found to be affected with FA due to hetero-
zygous FXN exonic deletion. Three of them (patients 1,
2, and 3) were previously reported in a series of patients
with an FA-like disease who presented with only 1 GAA
repeat expansion and no pointmutation.6 Themain find-
ings are summarized in Table 1 and Figure 1, and the
comparison between patients with FAexdel and pa-
tients with typical FA are presented in Table 2 and
Figure 2. Cardiomyopathy was diagnosed at 4 years of
age in patient 1 but was particularly stable until the pa-
tients turned 24 years of age. Patient 2 presented with
severe angina and cardiomyopathy with a left ventricu-
lar ejection fraction of 52% at 9 years of age that con-
fined her to a wheelchair. Interestingly, patient 3 was the
grandaunt of patient 2 (Figure 1); therefore, autosomal
dominant cerebellar ataxiawas first suspected in this fam-
ily. The high frequency of GAA expansion in heterozy-
gous carriers led to a pseudodominant inheritance of FA
in this family because the expansion of the 2 patients was
transmitted by 2 unrelated individuals (Figure 1). The 6
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Figure 1. Pedigree showing 4 generations of a family that included patient 2
(IV1) and patient 3 (II3) with pseudodominant inheritance of Friedreich
ataxia. The squares represent male individuals; circles, female individuals;
filled circles, affected female individuals; diagonal line, deceased individual;
arrow, proband. Genotypes are indicated as follows: E, GAA expansion;
exdel, exonic deletion; WT, wild type. ND indicates analysis was not done.
Table 2. Comparison Between Patients With FAexdel and Patients With Typical FA
Parameter
Typical FA
(n = 46)
FA exdel
(n = 6) P Value
Age at onset, mean (SD) [range], y 15.4 (5) [6-30] 7 (4) [3-12] .001
Time to confinement to wheelchair, median, y 28 20 .002
DD before confinement to wheelchair, median, y 13 9 .42
Age at last follow-up, mean (SD) [range], y 31 (10) [14-57] 33 (22) [9-69] .92
SARA score–to–DD ratio at last follow-up,a mean (SD) [range] 1.5 (0.6) [0.5-3] 1.9 (0.8) [1-3] .33
Cardiomyopathy, % of patients 68 84 .66
GAA triplet repeat sequences, mean (SD) [range], No. 634 (163) [367-1000],b
878 (220) [367-1667]c
780 (256) [340-1070] .10,b
.34c
Abbreviations: DD, disease duration; FA, Friedreich ataxia; FAexdel, FA due to an exonic deletion mutation; SARA, Scale for the Assessment and Rating of Ataxia.
aThis ratio calculation gives a good indication of the severity of the disease progression.
bShort expansion vs 780 (256) [340-1070].
cLarge expansion vs 780 (256) [340-1070].
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Figure 2. Data on patients with Friedreich ataxia due to an exonic deletion
mutation (FAexdel) and patients with typical FA who were not wheelchair
bound (determined by use of the Kaplan-Meier method).
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patients with FAexdel in our series are all of French an-
cestry: 2 patients are from southern France, and the other
4 patients, with a deletion of exons 4 and 5, were origi-
nally from Brittany, which suggests that the multiple oc-
currence of this deletion is the consequence of a founder
effect.
COMMENT
To our knowledge, we report the first series of 6 pa-
tients affected with FAexdel, which is characterized by
a particularly young age at onset in comparison with the
age at onset of typical FA. This comparison holds true
because there is no difference between the 2 groups re-
garding the size of GAA expansion (Table 2). The dis-
ease is more severe in patients with FAexdel, mainly be-
cause of the early onset of the disease and the early age
at which the patients become confined to a wheelchair
but also because there appears to be a trend toward a faster
progression of disability and a higher incidence of car-
diomyopathy in FAexdel. So far, only 1 patient with
FAexdel (with a deletion surrounding exon 5a) had been
reported with the disease at 9 years, sensory axonal neu-
ropathy, foot deformity, loss of independent walking at
15 years, and cardiomyopathy at 21 years.5 Early-onset
FA is a rare variant of FA, and patients whose age at on-
set is younger than 7 years represent approximately 12%
of all patients.1We found that FAexdel is exquisitely rare
and accounts for approximately 1% of cases of FA diag-
nosed in France.
It appears that extensor plantar reflexes are an op-
tional finding in FAexdel. Moreover, the incidence of ex-
traneurological signs is particularly high in such pa-
tients. All but 1 of our 6 patients were affected with
hypertrophic cardiomyopathy, albeit this is not signifi-
cantly different from the 60% of patients with typical FA
who have cardiomyopathy.1,7,9,10 However, the cardio-
myopathy may be particularly disabling in FAexdel, as
it lead to severe angina and early loss of ambulation in
patient 2. The incidence of diabetes mellitus was higher
in our patients with FAexdel (half of our patients were
affected) than in previously reported series of patients
with FA (about 30%).1,7 The incidence of scoliosis in our
patients with FAexdel seems to be the same as in pa-
tients with typical FA, but the severity of scoliosis could
be higher in FAexdel because 2 patients needed spine sur-
gery only a few years after onset of the disease. More-
over, scoliosis may reveal FAexdel (patient 2). Interest-
ingly, 3 patients had autonomic disturbances, especially
repeated ileus, which is an unusual finding in FA.11 The
severe phenotype associated with exonic deletion mu-
tation is in agreement with the predicted absence of func-
tional frataxin made from the deleted allele.
It appears that exonic deletion significantly contrib-
utes to the clinical picture of patients with FA, espe-
cially to the young age at onset of the disease, whereas
the FA phenotype and the age at onset are usually con-
ditioned by the size of the smaller GAA expansion (in
case of homozygous expansions).1,6,7,12 For instance, pa-
tients with a short size of the smaller expansion may
present with an FA variant such as late-onset FA1,13,14 or
very-late-onset FA,1,15,16 defined by an age at onset of the
disease of older than 25 and 40 years, respectively.Within
our series, it seems that the size of the GAA expansion
also contributes to the phenotype. Indeed, the 3 pa-
tients with the larger expansions (patients 1, 3, and 6,
presenting with 1070, 970, and 830 GAA triplet repeat
sequences, respectively) are those affected with both dia-
betes mellitus and autonomic disturbances, and patient
2 (800 GAA triplet repeat sequences) had had the first
signs at 2 years of age, a severe cardiomyopathy at 4 years
with angina at 9 years, and the shorter disease duration
before becoming wheelchair bound. Moreover, patient
5, with the shortest expansion (340 GAA triplet repeat
sequences) and deletion of exons 4 and 5, does not show
symptoms of an extensor plantar response, cardiomy-
opathy, or diabetes mellitus.
FXN should be investigated for exonic deletion in pa-
tients with early-onset FA in which only 1 GAA expan-
sion without a point mutation is found. In clinical prac-
tice, patients with FAexdel have to be carefully observed
using cardiological, orthopaedic, endocrinological, gas-
troenterological, and ophthalmological data. Moreover,
FAexdel should be suspected in young patients present-
ing with severe scoliosis.
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